Clinical observation of type 2 diabetes based on insulin aspart 30 injection combined acarbose tablets treat-ment

VernacularTitle:门冬胰岛素30联合阿卡波糖治疗2型糖尿病的临床观察
Author: Xiuli HE
Publication Type:Journal Article
Keywords: Insulin aspart 30 injection; Acarbose tablets; Diabetes,type 2
From: Chinese Journal of Primary Medicine and Pharmacy 2015;(11):1609-1611
CountryChina
Language:Chinese
Abstract: Objective To discuss the efficacy and safety of insulin aspart 30 injection combined with Akabo Tang (Acarbose tablets)about treatment of patients with type 2 diabetes.Methods 36 cases of type 2 diabetes were selected,by means of insulin aspart 30 combined acarbose tablets treatment,the levels of fasting plasma glucose (FPG)and glycosylated hemoglobin(HbA1c)before and after treatment were observed.Results The levels of fasting plasma glucose were (10.67 ±2.00)mmol/L and (6.76 ±0.47)mmol/L before and after treatment;The levels of HbA1c were (9.54 ±1.90)% and (7.70 ±0.82)% before and after treatment.After treatment,blood glucose and glycated hemoglobin levels in patients were significantly decreased (t =31.920,P <0.05;t =29.624,P <0.05). Conclusion The treatment that insulin aspart 30 injection combines acarbose tablets for type 2 diabetes patients is a safe,effective and convenient option.